33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.54%
Revenue growth 1.25-1.5x BRZE's 11.52%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
13.47%
Gross profit growth at 75-90% of BRZE's 15.98%. Bill Ackman would demand operational improvements to match competitor gains.
-9.37%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.37%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-6.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-6.25%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-6.25%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-11.88%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-100.00%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
100.00%
Similar to BRZE's 100.00%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-100.00%
We’re deleveraging while BRZE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
16.60%
R&D growth drastically higher vs. BRZE's 30.45%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.50%
SG&A growth well above BRZE's 14.32%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.